Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPsyence Biomedical Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/30/2023 | Q3 2023 | -$1.85 | $0 | |||
| 09/29/2023 | Q2 2023 | -$0.08 | $0 | |||
| 06/28/2023 | Q1 2023 | -$0.01 | $0 | |||
| 03/29/2023 | Q4 2022 | -$0.00 | $0 | |||
| 12/29/2022 | Q3 2022 | $0.00 | $0 | |||
| 09/28/2022 | Q2 2022 | $0.03 | $0 | |||
| 06/28/2022 | Q1 2022 | $0.07 | $0 | |||
| 03/29/2022 | Q4 2021 | $0.10 | $0 | |||
| 12/29/2021 | Q3 2021 | $0.25 | $0 | |||
| 09/28/2021 | Q2 2021 | -$0.00 | $0 |
Psyence Biomedical Ltd. Earnings: FAQ's
How can I listen to Psyence Biomedical Ltd.'s earnings conference
call?
The conference call for Psyence Biomedical Ltd.'s latest earnings report can be listened to online.
How can I read Psyence Biomedical Ltd.'s conference call transcript?
The conference call transcript for Psyence Biomedical Ltd.'s latest earnings report can be read online.
How much profit does Psyence Biomedical Ltd. generate each year?
Psyence Biomedical Ltd. (:PBM) has a recorded net income of $0. Psyence Biomedical Ltd. has generated $-7.85 earnings per share over the last four quarters.
What is Psyence Biomedical Ltd.'s price-to-earnings ratio?
Psyence Biomedical Ltd. (:PBM) has a price-to-earnings ratio of -1.38 and price/earnings-to-growth ratio is 0.